iPSC Cell Therapy Moves From Lab Bench to Clinical Trials
A review of iPSC-based regenerative medicine charts the path from Parkinson's disease models to real-world cell replacement therapies.
Stem cell therapies, regenerative medicine, tissue engineering, and cellular reprogramming
170 articles
A review of iPSC-based regenerative medicine charts the path from Parkinson's disease models to real-world cell replacement therapies.
Discover exosomes — the microscopic 'text messages' your cells send to coordinate healing, aging, and repair throughout your body.
Astellas reports encouraging early-stage results for a stem cell-derived treatment targeting age-related eye disease, though data remains limited.
A comprehensive review maps how mesenchymal stem cells and their exosomes combat Alzheimer's, atherosclerosis, osteoporosis, and ovarian failure.
A novel photoactivatable drug system uses NK immune cells to eliminate aging joint cells, reducing osteoarthritis progression in mice.
Combining nanoparticles with mesenchymal stem cells could finally overcome the poor survival and differentiation that limits cartilage regeneration.
A translational review outlines how stem cell technologies may finally make hepatocyte-based liver therapies clinically viable.
Human stem cells that migrate through 3µm channels spontaneously begin differentiating into bone cells — no chemical signals required.
A new review examines how umbilical cord-derived stem cells may repair dopaminergic neurons and slow Parkinson's progression beyond symptom relief.
Packaging mitochondria in erythrocyte-derived membranes dramatically improves delivery efficiency, pushing this experimental therapy closer to clinical reality.
A novel anti-swelling hydrogel loaded with dasatinib, quercetin, and nucleus pulposus exosomes clears senescent cells and restores disc integrity in rats and goats.
Scientists converted fibroblasts into functional osteoblasts using small molecules, then formed transplantable spheroids that repair bone defects without scaffolding.